P Peris
Overview
Explore the profile of P Peris including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
689
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salmoral A, Peris P, Lopez Medina C, Florez H, Barcelo M, Pascual Pastor M, et al.
Osteoporos Int
. 2024 Dec;
36(2):245-254.
PMID: 39623217
Objective: The optimal length of bisphosphonate discontinuation is unknown, as is the type of patient who could benefit from this approach. The objectives of the study were to analyze, in...
2.
Yanes M, Diaz-Curiel M, Peris P, Vicente C, Marin S, Ramon-Krauel M, et al.
Orphanet J Rare Dis
. 2022 Jul;
17(1):298.
PMID: 35906684
Background: Health-related quality of life (HRQoL) of patients with X-linked hypophosphatemia (XLH) is lower than that of both the general population and the patients with other chronic diseases, mainly due...
3.
Riancho J, Peris P, Gonzalez-Macias J, Perez-Castrillon J
Rev Clin Esp (Barc)
. 2022 Jun;
222(7):432-439.
PMID: 35676194
This updated version of the Spanish Society for Research in Osteoporosis and Mineral Metabolism (SEIOMM) osteoporosis guides incorporate the most relevant information published in the last 7 years, since the...
4.
Florez H, Hernandez-Rodriguez J, Carrasco J, Filella X, Prieto-Gonzalez S, Monegal A, et al.
Osteoporos Int
. 2021 Sep;
33(3):745-750.
PMID: 34557953
Introduction: Osteocalcin (OC) is involved in the regulation of glucose homeostasis. Glucocorticoid (GC) treatment is associated with impaired osteoblast function, decreased OC levels, and the development and/or worsening of pre-existing...
5.
Kanterewicz E, Puigoriol E, Rodriguez Cros J, Peris P
Osteoporos Int
. 2019 Jul;
30(9):1901-1902.
PMID: 31317247
Figure 1 as published in the original version of this article was unfortunately incomplete.
6.
Kanterewicz E, Puigoriol E, Rodriguez Cros J, Peris P
Osteoporos Int
. 2019 May;
30(10):2141-2149.
PMID: 31123788
Purpose: Vertebral fracture assessment (VFA) is increasingly used to identify spine fractures, but few cohort studies have used this method in prevalence and incidence assessment. We previously reported the prevalence...
7.
Redondo L, Puigoriol E, Rodriguez J, Peris P, Kanterewicz E
Rev Clin Esp (Barc)
. 2018 Jan;
218(3):121-127.
PMID: 29329765
Introduction And Objectives: The trabecular bone score (TBS) is an imaging technique that assesses the condition of the trabecular microarchitecture. Preliminary results suggest that TBS, along with the bone mineral...
8.
Gifre L, Humbert L, Muxi A, Del Rio L, Vidal J, Portell E, et al.
Osteoporos Int
. 2017 Oct;
29(1):201-209.
PMID: 29043391
Introduction: SCI is associated with a marked increase in bone loss and risk of osteoporosis development short-term after injury. 3D-DXA is a new imaging analysis technique providing 3D analysis of...
9.
Gifre L, Ruiz-Gaspa S, Carrasco J, Portell E, Vidal J, Muxi A, et al.
Osteoporos Int
. 2017 Jun;
28(9):2707-2715.
PMID: 28580511
Introduction: Bone turnover and bone loss are markedly increased shortly after SCI. However, the pathogenesis and clinical management of this process remain unclear, especially the role of the osteoprotegerin (OPG)/RANKL...
10.
Peris P, Filella X, Monegal A, Guanabens N, Foj L, Bonet M, et al.
Osteoporos Int
. 2017 May;
28(8):2457-2464.
PMID: 28466136
Introduction: Determination of 25-OH vitamin D serum levels (25-OHD) constitutes the method of choice for evaluating vitamin D deficiency. However, vitamin D-binding protein (DBP) may modulate its bioavailability thereby affecting...